Press Release

Kirkland Advises Option Care Health in Merger with Amedisys

Kirkland & Ellis represents Option Care Health, Inc. (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, which, along with Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, today announced that they have entered into a definitive merger agreement to combine in an all-stock transaction that values Amedisys at approximately $3.6 billion, including the assumption of net debt.


Together, Option Care Health and Amedisys will have a national clinical workforce of more than 16,500 professionals and 674 care centers across the U.S. committed to delivering high-quality alternate site care. Based on recently reported 2022 financial results, the combined company generated revenues of approximately $6.2 billion.


The transaction was approved by the boards of directors of both companies and is expected to close in the second half of 2023, subject to approval by Option Care Health and Amedisys stockholders, other customary closing conditions and regulatory approvals.


Read more in Option Care Health’s press release


The team was led by corporate partners Carlo Zenkner, Sarkis Jebejian and Mark Fennell and associate Alexandra Gallogly and capital markets partner Ross Leff, along with corporate partner Shaun Mathew and associates Will Pretto and Josh Sullivan, capital markets partner Zoey Hitzert and associates Devansi Reshamwala and Pratik Das, executive compensation partners Michael Krasnovsky and Matthew Wood and associates Jenny Cha and Dominique Collins, employee benefits partner Robert Zitko and associate Hannah Barlow, debt finance partners Maureen Dixon and Daniel Schwimmer and associate Neal Loughery, tax partners Rachel Cantor and Heidi Yuen and associate Michael Alcan, antitrust partners Matt Reilly, Chuck Boyars and Matt Wheatley, healthcare regulatory partners Dennis Williams and Lindsay Borgeson and associates Jamie Feyko, Maureen Gallagher and Olivia Seraphim, technology & IP transactions partners Jeffrey Seroogy and Neil Hirshman and associates Amani Coutinho and Josefin Sjoestroem, labor & employment partner Christie Alcala and associates Kayla Davis and Olivia Hunter, real estate partner John Caruso and associate Chrisa Kouskoulas and environmental transactions partner Sarah Webber and associate Matt Swanson.